Healthcare Jul 05, 2021 10:38 AM (GMT+8) · EqualOcean
Yiou health learned on the 5th that Suzhou caike Biotechnology Co., Ltd. (hereinafter referred to as "Suzhou caike") has recently completed A-1 and A-2 rounds of financing. Among them, round A-1 financing is jointly led by IDG capital and Langyu capital, and round A-2 financing is jointly led by IDG capital and Perkin Elmer venture capital. The funds obtained in the two rounds will be mainly used for the further investment in R & D, the construction of talent team and the commercialization of products. Suzhou caike, founded in 2018, is a company providing advanced research tools for life science, focusing on developing efficient technology platform to mine high-resolution massive life science data. At present, the core technology platform of Suzhou Color Technology Co., Ltd μ- MFP (micro scaled multi physics coupled force) has built a number of application platforms, including ultra-high sensitivity biomolecular detection platform, multiple magnetic fluorescent coding microspheres platform for multi index joint detection, and high-throughput single cell parallel control platform for multi omics.